Back to Agenda
Session 3 (continued): Research and Related Initiatives to Evaluate and Improve Real-World Evidence and Real-World Data
Session Chair(s)
John Concato, MD, MPH, MS
Associate Director for Real-World Evidence Analytics, OMP, CDER
FDA, United States
Delphine Saragoussi, MD, MSc
Executive Director, Epidemiology and Scientific Affairs
PPD, part of Thermo Fisher Scientific, France
Part 2: Continue the discussion now focusing on regulatory agency perspective.
Speaker(s)
![Kenneth Quinto, MD, MPH](/_Images/member/Generic_Image_Missing-Profile.jpg)
Speakers
Kenneth Quinto, MD, MPH
FDA, United States
Senior Medical Advisor for Real World Evidence Analytics, OMP, CDER
Speaker
Laura Esserman, MD, MBA
UCSF, United States
Director, Breast Care Center; Professor of Surgery and Radiology
Speaker
Michele Jonsson Funk, PhD, FISPE
University of North Carolina at Chapel Hill, United States
Associate Professor of Epidemiology; Director, Center for Pharmacoepidemiology
Speaker
Catherine Cohet, PhD
European Medicines Agency, Netherlands
Senior Pharmacoepidemiologist, Data Analytics and Methods Task Force
Have an account?